Clinical Trials Logo

Chinese Medicine clinical trials

View clinical trials related to Chinese Medicine.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04310865 Suspended - COVID-19 Clinical Trials

Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Start date: November 2021
Phase: Phase 2/Phase 3
Study type: Interventional

In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia caused by CoVID-19, and the number of cases of infection with CoVID-19 identified in Wuhan increased markedly over the later part of January 2020, with cases identified in multiple other Provinces of China and internationally.Given no specific antiviral therapy for CoVID-19 infection and the availability of Yinhu Qingwen Granula as a potential antiviral Chinese medicine based on vivo antiviral studies in CoVID-19, this adaptive, randomized,double-blind,controlled trial will evaluate the efficacy and safety of Yinhu Qingwen Granula in patients hospitalized with severe CoVID-19.

NCT ID: NCT04278963 Suspended - CoVID-19 Clinical Trials

Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19

Start date: October 2021
Phase: Phase 2/Phase 3
Study type: Interventional

In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia caused by CoVID-19, and the number of cases of infection with CoVID-19 identified in Wuhan increased markedly over the later part of January 2020, with cases identified in multiple other Provinces of China and internationally. Given no specific antiviral therapy for CoVID-19 infection and the availability of Yinhu Qingwen Decoction as a potential antiviral Chinese medicine based on vivo antiviral studies in CoVID-19, this randomized,three-arm controlled, single-blind trial will evaluate the efficacy and safety of Yinhu Qingwen Decoction (Granula) in patients hospitalized with mild or common CoVID-19 respiratory disease.

NCT ID: NCT02559960 Suspended - Adverse Drug Event Clinical Trials

Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

Start date: September 2015
Phase:
Study type: Observational

This registry aims to monitor the safety of Breviscapine Powder-Injection and to identify the potential risk factors for the adverse drug reactions.